47
Growth Score
pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Regenesance focuses on developing drugs to treat acute and chronic nerve disorders.
Frank Baas: CSO
About the Company
Regenesance BV was founded in november, 2009 on groundbreaking research from the academic medical center. AMC researchers found that an innate part of the immune system (complement pathway) is activated after nerve damage to produce a lytic complex (called the membrane attack complex or MAC). Normally, the MAC attacks pathogens and helps remove
tissue debris following trauma. However, AMC researchers learned that MAC can also damage nerves, particularly those attempting to regrow after injury. This work indicates that a variety of acute or chronic nervous system disorders may benefit from new therapies that strategically control MAC activation.
